Investors Love Sandoz: Swiss Pharma Stock Surges on Robust Generics & Biosimilars Growth
Strong gains for Sandoz (SDZ.SW) as it outpaces the Swiss market—leveraging its leading generic & biosimilar portfolio for a promising growth outlook.
3 minutes to read
